Foraco International
TSE:FARForaco International SA, together with its subsidiaries, provides drilling services in North America, Europe, the Middle East, Africa, South America, and the Asia Pacific. It operates through two segments: Mining and Water. The company offers exploration, development, and production drilling services to the mining industry for energy transition, gold, and mineral exploitation; and various geological sampling and testing techniques, including chips and cores, stabilized holes for blasting, logging, boreholes to be used for injection of water or acid, cold water injection, production boreholes, large diameter core, and dual tube rotary bulk samples. It also installs production pumps for dewatering purposes; and provides drift stabilization or water table protection for decommissioning of mineral production facilities. In addition, the company drills wells for drinking, irrigation, and industrial water; undertakes a range of projects, including village water drilling programs, specialized drilling projects to access mineral water using sanitary protection methods for the bottled water industry, and large diameter well fields for residential supply in urban environments; and offers inspection, servicing, and rehabilitation services for existing wells. In addition, the company offers drilling services for the environmental and construction industry, such as geological exploration and geotechnical drilling. It serves mining companies and official development assistance providers. Foraco International SA was founded in 1961 and is headquartered in Marseille, France.
Hospira
NYSE:HSPHospira, Inc. provides injectable pharmaceutical drugs and infusion technologies and it develops, manufactures, distributes and markets biosimilars. The Company's portfolio includes generic acute-care and oncology injectables, biosimilars, and integrated infusion therapy and medication management products. The Company conducts operations across the world and is managed in three segments: the Americas, which include the United States, Canada, and Latin America; Europe, Middle East, and Africa (EMEA), and the Asia Pacific, which includes Asia, Japan, Australia and New Zealand. Its portfolio of products includes Specialty Injectable Pharmaceuticals, which includes generic injectables, injectables and biosimilars, Medication Management and Other Pharmaceuticals. Its portfolio of products is used by hospitals and alternate site providers, such as clinics, home healthcare providers and long-term care facilities.
Lumina Gold
CVE:LUMLumina Gold Corp., a precious and base metals exploration and development company, engages in the acquisition, exploration, evaluation, and development of mineral resources in Ecuador. The company primarily explores for gold and copper deposits. It focuses on the Cangrejos Gold-Copper Project located in El Oro Province, southwest Ecuador. The company was formerly known as Odin Mining and Exploration Ltd. and changed its name to Lumina Gold Corp. in November 2016. Lumina Gold Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
Trilogy Metals
NYSEAMERICAN:TMQTrilogy Metals Inc., a base metals exploration company, engages in the exploration and development of mineral properties in the United States. The company explores for copper, cobalt, lead, zinc, gold, and silver properties. It principally holds interests in the Upper Kobuk mineral projects that include the Arctic, which contains polymetallic volcanogenic massive sulfide deposits; and Bornite that contains carbonate-hosted copper - cobalt deposits covering an area of approximately 448,217 acres located in the Ambler mining district in Northwest Alaska. The company was formerly known as NovaCopper Inc. and changed its name to Trilogy Metals Inc. in September 2016. Trilogy Metals Inc. was founded in 2004 and is headquartered in Vancouver, Canada.